Business Description
Medicus Pharma Ltd
NAICS : 325412
SIC : 3741
ISIN : CA58471K1030
Compare
Compare
Traded in other countries / regions
MDCX.CanadaMDPLF.USAN46.Germany IPO Date
2024-01-18Description
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.84 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.25 | |||||
| 9-Day RSI | 69.45 | |||||
| 14-Day RSI | 69.47 | |||||
| 6-1 Month Momentum % | 45.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.11 | |||||
| Quick Ratio | 4.11 | |||||
| Cash Ratio | 1.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -345.68 | |||||
| ROIC % | -142.48 | |||||
| ROC (Joel Greenblatt) % | -532.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 7.93 | |||||
| Price-to-Tangible-Book | 7.93 | |||||
| EV-to-EBIT | -4.33 | |||||
| EV-to-EBITDA | -4.35 | |||||
| EV-to-FCF | -6.59 | |||||
| Price-to-Net-Current-Asset-Value | 8.22 | |||||
| Price-to-Net-Cash | 88.8 | |||||
| Earnings Yield (Greenblatt) % | -23.09 | |||||
| FCF Yield % | -14.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicus Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.335 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 69.47 | ||
| 14-Day ATR (€) | 0.09266 | ||
| 20-Day SMA (€) | 4.394 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 1.36 - 4.8 | ||
| Shares Outstanding (Mil) | 10.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicus Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicus Pharma Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicus Pharma Ltd Frequently Asked Questions
What is Medicus Pharma Ltd(STU:N460)'s stock price today?
The current price of STU:N460 is €4.18. The 52 week high of STU:N460 is €4.80 and 52 week low is €1.36.
When is next earnings date of Medicus Pharma Ltd(STU:N460)?
The next earnings date of Medicus Pharma Ltd(STU:N460) is .
Does Medicus Pharma Ltd(STU:N460) pay dividends? If so, how much?
Medicus Pharma Ltd(STU:N460) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers